We studied the effect of CF serum on the phagocytic function of normal and CF human alveolar macrophages to determine if the chronic pulmonary infection in CF patients results from a defect in phagocytosis. Alveolar macrophages were obtained by fiberoptic bronchoscopy and cultured overnight on glass surfaces; the uptake of radioactive bacteria was then measured in the presence of normal or CF sera.
Babies and Childrens Hospital, Case Western Reserve University, Cleveland, Ohio.
We studied the effect of CF serum on the phagocytic function of normal and CF human alveolar macrophages to determine if the chronic pulmonary infection in CF patients results from a defect in phagocytosis. Alveolar macrophages were obtained by fiberoptic bronchoscopy and cultured overnight on glass surfaces; the uptake of radioactive bacteria was then measured in the presence of normal or CF sera.
19 of 21 CF sera produced >30% inhibition of phagocytosis of Pseudomonas aeruginosa, and had no apparent effect on phagocytosis of Staphylococcus aureus by normal human nacrophages. Alveolar macrophages from CF patients were able to phagocytize Pseudomonas in the presence of normal sera, but were inhibited by both autologous and homologous CF sera. Incubation 2f normal macrophages with a mixture of normal and CF serum did not reduce the degree of inhibition of Pseudomonas phagocytosis. These results suggest that CF alveolar macrophages may function xomally in a suitable environment, and that CF serum contains a factor which inhibits phagocytosis of Pseudomonas. This factor . s unaffected by freezing or heating at 56' for 30 minutes, and .s not adsorbed onto glass.
The chronic Pseudomonas pulmonary .nfection of CF may be due to a factor in the lung environment txtrinsic to the macrophages, rather than to an intrinsic defect Ln the alveolar macrophages themselves. tion may result from defective or innnature lymphokine production Thus, we assessed monocyte migration inhibition factor (MIF) and interferon (IF) production of the lymphocytes of 20 newborns (cord blood). 20 1-7 day old neonates. and 20 normal adults. Ficoll-hypaque separated mononuclear cells were stimulated with ph tohemagglutinin (PHA), allogeneic lymphocytes in a mixed leukocy culture (MLC), or Newcastle Disease Virus (NDV), and supernatant were harvested at optimp1 times. MIF was assessed by the inhibi tion of adult mononuclear cell migration under agarose; IF was assessed by micro-dye uptake of human diploid cells after enceph lomyocarditis virus challenge. Mean PHA-induced MIF production in cord and newborn lymphocytes was 30 and 10% respectively of Stimulated T cells produced SIF continuously by 5 days of culture while LMF production ceased after 72 hours. SIF and LMF were separated on Sephadex G200; SIF occurred predominantly in the exclusion column, and LMF exclusively in the postalbumin fraction. Serum from a man with an unusual skin lymphoma had potent SIF-like activity. That the serum SIF activity originated from the lymphoma was suggested by the fact that supernatants from skin tumor cells potently inhibited PHA-induced mitosis of lormal T cells. The patient's peripheral blood lymphocytes were mresponsive to antigens and mitogens in autologous serum, but responded normally in homologous serum. This tumor appears to represent an abnormal extension of a physiological process.
Supported by U.S. Public Health Service Research Grant 11-05877. CM is a new cephalosporine (CSP) with an expanded spectrum against gram negative organisns. 34 newborn infants (mean age 17 days, weight 3.6 kg),32 with pustular skin infection and 2 with clinical sepsis (CS) were treated with 33 mg/kg of CM q 8 h IM for 7 days. Gentamicin was given to the 2 CS patients in addition. S.aureys (SA) was isolated in 25 cases and each was sensitive to CM. Blood cultures in all were sterile. All patients improved clinically and skin lesions disappeared by 5th day. A discrepancy between the MIC and the MBC of penicillin (pen) against GBS has been reported, suggesting that the relapses of GBS disease after treatment with conventional doses of pen may be a result of this discrepancy. In this study, we measured pen MIC and MBC levels against GBS and compared them with levels obtained for GAS, an organism that has been successfully treated for years with conventional doses of pen without evidence of relapse in normal hosts. These experiments confirmed the reports that a large MIC/MBC discrepancy exists in GBS(10 fold); however, a larger discrepancy exists for GAS(25 fold). These findings diminish the likelihood of clinical significance of the MIClMBC ratio alone in accounting for the relative difficulty in treatin? GBS. Other factors, such as the lower absolute sensitivity of GBS to pen compared to that of GAS, must be playing a role: both the MIC and the MBC values were significantly higher for GBS than for GAS.
